steve schwartz brooks life sciences sample managementmanagement+-+steve... · & inventory mgmt....
TRANSCRIPT
Market-leading sample management solutions
Steve SchwartzBrooks Life SciencesSample Management
© 2019 Brooks Automation, Inc. • Proprietary Information
AGENDA
Leading Player in Sample Management. Growth Set to Accelerate.
61
Market positioning
Growth strategies
Sample Management today
Business model and outlook
© 2019 Brooks Automation, Inc. • Proprietary Information
Sample Management at a Glance
* LTM results to June 2019 62
Revenue Breakdown (LTM)
OutsourcedStorage Services
Consumables & InstrumentsStore Systems
& Service
26%
44%
30%
Key Metrics
$205M
~$7B
>60
>1,500
58%
Revenue*
Served market
Countries
Customers
Recurring revenue
~800Global employees
© 2019 Brooks Automation, Inc. • Proprietary Information
Automation for
Sample Storage
Consumables
& InstrumentsBioStorage
Genomic
Analysis
Sample Tracking
& Inventory Mgmt.
Informatics
Leader in Differentiated, Integrated Products and Services
63
• Bio III Cryo Store (-196C)
• Bio Store (-80C)
• Sample Store (-20C)
• Clinical Bio Store (+4C)
• FluidX®
• 4titude®
• Biocision®
• REMP®
• IntelliXcap®
• BioStorage
(off-site and on-site)
• Cold-Chain Transport
and Logistics
• Integrated Storage
and Services
• FreezerPro®
• BioBankPro®
• PlatformOne®
• Genomic Analysis
and Lab Services
• Sample Prep and
DNA Extraction
• Sample Kits and
Logistics
30% 26%
44%
© 2019 Brooks Automation, Inc. • Proprietary Information
FY13 FY14 FY15 FY16 FY17 FY18 FY19
Systems & Service
FY13 FY14 FY15 FY16 FY17 FY18 FY19
Consumables & Instruments
FY13 FY14 FY15 FY16 FY17 FY18 FY19
Storage
FY13 FY14 FY15 FY16 FY17 FY18 FY19
Genomics
64
Underlying Business Segments are All Strong – Either Stable or Growing
FY13 FY14 FY15 FY16 FY17 FY18 FY19
Systems
& Service
C&I
Storage
Genomics
$43M
$63M $68M
$108M
$149M
$197M~$205M*
• Robust offerings
• All areas expanding over time
Portfolio is ResilientTotal Sample Management Revenue
© 2019 Brooks Automation, Inc. • Confidential and Proprietary Information * FY’19 - Management’s estimate
© 2019 Brooks Automation, Inc. • Proprietary Information 65
The Challenge in 2019 – Short-Term Deceleration of Organic Growth
• Lumpy top 4 customer revenues
• Market coverage concentration issues
FY13 FY14 FY15 FY16 FY17 FY18 FY19
$197M~$205M*
+14%Organic Growth
~7%Organic Growth
Major Reasons for
Deceleration
Total Sample Management Revenue
$43M
© 2019 Brooks Automation, Inc. • Proprietary Information * FY’19 - Management’s internal estimate
© 2019 Brooks Automation, Inc. • Proprietary Information
FY13 FY14 FY15 FY16 FY17 FY18 FY19
A C L O S E R L O O K
Short Term Growth DecelerationKey Reason: Variability in Top 4 Customers
FY13 FY14 FY15 FY16 FY17 FY18 FY19
Removing the Top 4Shows 1,500 Customers
Generating 80% of Revenueare Growing Steadily
The Top 4 Customers Account for 20% of
Revenues and are Lumpy
A Closer Look atOverall Growth Slowing
in 2019 Showing Top 4 Customers
FY13 FY14 FY15 FY16 FY17 FY18 FY19FY13 FY14 FY15 FY16 FY17 FY18 FY19
66
+14%Organic Growth
~7%OrganicGrowth
~15%OrganicGrowth
* FY’19 - Management’s internal estimate
© 2019 Brooks Automation, Inc. • Proprietary Information
We Remain Highly Confident in the Long-Term Growth of the Business
* Based on 3rd party Market study commissioned by the company 67
Growth in Sample StorageAddressable Market*
(Number of Samples)
Other
• Translational
Samples
• Pathology
• API
~3% Share of a $7BSample Storage Market*
CellLines
ClinicalResearchSamples
DiscoveryResearch
CompoundStorage
ClinicalTrials
1.8B
2.6B
2018 2022
+10%CAGR
Brooks will grow faster due to
• Automation
• Outsourcing
© 2019 Brooks Automation, Inc. • Proprietary Information 68
Market positioning
Growth strategies
Sample Management today
Business model and outlook
AGENDA
Leading Player in Sample Management. Growth Set to Accelerate.
© 2019 Brooks Automation, Inc. • Proprietary Information
Customer Workflow-Driven Business Model
69
Research / Clinical Research Sample Workflow
Transport Process Store Retrieve Informatics
End to end solutions to ensure sample integrity
Kit
© 2019 Brooks Automation, Inc. • Proprietary Information
CompanyKitting,
Logistics and Transport
Storageand Archival
Services
On PremiseLab Services
Clinical Trial Collection Mgmt& Coordination
Integrated Sample Mgmt
Software
Global Capabilities
Top 20Pharma
Life Sciences
Tools Competitor
Central Lab
Competitor
Diversified Catalog
Distributor Competitor
U N I Q U E LY P O S I T I O N E D :
THE Most Comprehensive, One-Stop Sample Management Customer Solution in the Industry
Complete End-to-End Solutions
70
✓ ✓ ✓ ✓ ✓ ✓✓
✓ ✓ ✓✓
✓ ✓ ✓
✓ ✓
Brooks’ business model provides clear competitive differentiation
© 2019 Brooks Automation, Inc. • Proprietary Information
Barriers
to Entry
World Class Sample Management Requires Unique Expertise – Creates Barriers to Entry
Specialty care
Disposal / verification
Global coordination
Cold chain logistics
FDA audit Trail
Lab services
Retrieval / archival
Tracking
71
Brooks leverages its global capabilities to maintain competitive advantage
High Standards of Cell Based Science
© 2019 Brooks Automation, Inc. • Proprietary Information
Our Expertise has Allowed Us to Win an Impressive Global Customer Base
1,500+ leading healthcare companies depend on Brooks
72
Healthcare / Clinical Academic / GovtPharma / Biotech
© 2019 Brooks Automation, Inc. • Proprietary Information 73
Market positioning
Growth strategies
Sample Management today
Business model and outlook
AGENDA
Leading Player in Sample Management. Growth Set to Accelerate.
© 2019 Brooks Automation, Inc. • Proprietary Information
Opportunities to Leverage Strengths in Pharma / Biotech and Expand Rapidly in Less Penetrated Spaces
74
Healthcare / Clinical Academic / GovtPharma / Biotech
Market Size Brooks Revenue
LEVERAGE PENETRATE / GROW PENETRATE / GROW
Market Size Brooks Revenue Market Size Brooks Revenue
$1.2B*
$3.9B*$1.7B*
$157M
$24M $24M
2019 2019 2019
✓
✓
✓
✓
✓
✓
* Based on 3rd party Market study commissioned by the company
© 2019 Brooks Automation, Inc. • Proprietary Information
Key Growth Strategies
75
Leverage strong position in Pharma / Biotech
Target and grow in less penetrated spaces
Capitalize on outsourcing and automation trends
1
2
3
© 2019 Brooks Automation, Inc. • Proprietary Information
G R O W T H S T R AT E G Y # 1
Leverage Strong Position in Pharma & Biotech
Brooks is the trusted source for Pharma / Biotech
76
Pharma
• Higher penetration, leveraging capital outside the company
• Solid, more mature growth rate
Biotech
• Lower current penetration, more targets, diverse needs
• Often no need to handle samples inside Biotech, but need to retrieve data and maintain sample database
• Long-term double-digit growth as many realize approvals and expansion
Pharma / Biotech Opportunities
© 2019 Brooks Automation, Inc. • Proprietary Information
G R O W T H S T R AT E G I E S # 2
Target and Grow in Less Penetrated Spaces
1,500+ leading healthcare companies depend on Brooks
77
Healthcare / Clinical
• Largest market, steady growth
• Less penetration, but strong proof points with Cleveland Clinic, Mt.Sinai, Sloan Kettering, Mayo Clinic, Karolinska
• Additional growth rate opportunity
Academic / Gov’t
• Low penetration, target rich in Academic
• Academics outsource when pressed
• Gov’t studies are opportunistic, more international than US based
• Brooks double digit growth rate opportunity driven by clinical
Healthcare / Clinical Academic / Govt Opportunities
© 2019 Brooks Automation, Inc. • Proprietary Information
G R O W T H S T R AT E G Y # 3
Outsourcing and Automation – High Growth Areas
78
Automation Opportunities
Outsourcing Opportunities
• Many sample collections are out-growing customers ability to manage
• ~25% of companies outsource sample storage – still a large untapped opportunity
• 2/3 of those who did not outsource indicate they will consider it
• Biological sample integrity favors automated collections
• Cell and gene therapy and IVF samples require automated storage to assure cell viability
• Large population and specific disease studies utilize automated storage
© 2019 Brooks Automation, Inc. • Proprietary Information 79
Market positioning
Growth strategies
Sample Management today
Business model and outlook
AGENDA
Leading Player in Sample Management. Growth Set to Accelerate.
© 2019 Brooks Automation, Inc. • Proprietary Information
High Recurring Revenues Recurring Revenues Growing Steadily
Building On an Attractive Business Model –Increasing Resilience with Recurring Revenue Base
8080
Recurring
58% Recurring RevenueFY14 FY15 FY16 FY17 FY18 FY19
$63M $68M
$108M
$149M
$205M*$197M
AutomatedSolutions
23%
Services / Informatics
57%
Consumables Instruments
20%
Recurring
Transactional
41% 58%
65%58%
57%58%
~
* FY’19 - Management’s estimate
© 2019 Brooks Automation, Inc. • Proprietary Information
Growth with Profit
$197
$280
2018 2022
$4
$42-50
2018 2022
Sample Management – Significant Operating Leverage Going Forward
81
Investment
• Localized sales and service infrastructure to support high growth in China
• Facility expansions to support increased samples under storage and management
Operating leverage
• Scalable OPEX structure
• Project management discipline
• Supply chain optimization
Significant leverage equation:~40-50% income per $1M revenue
Revenue($M)
9%CAGR
Operating Income*($M)
~90%CAGR
* Non-GAAP financial measure – See reconciliation tables
© 2019 Brooks Automation, Inc. • Proprietary Information
Returning to Double Digit Growth
$197 ~$205$220
$280
2018 2019 2020Target
2022 Target
Revenue ($M) Operating Margin*
2%~4%
~9%
15-18%
2018 2019 2020Target
2022Target
82
13%CAGR
7%CAGR
~15 pts
Moderating near-term expectations to single digit growth consistent with recent performance, confident in long term opportunity and actions
* Non-GAAP financial measure – See reconciliation tables
© 2019 Brooks Automation, Inc. • Proprietary Information
2022 Target Model - Sample Management
LifeSciences FY18 FY22
Growth / Change
Revenue $197M $280M 9% CAGR
Gross
Margin*38% 42-44% +4-6 pts
Operating
Margin*2% 15-18% +13-16 pts
• Cr
Strong market
growth
Synergy of Sample
Management and
GENEWIZ
Operating margin
expansion
• 10% growth in samples
globally with trends toward
outsourcing and automation
• Current structure affords
redeployment of
investment for growth
83
Drivers Target Model
• Value-added services and
cross-sell opportunities
Product and
Service breadth
• Most comprehensive, one-
stop sample management
solutions
* Non-GAAP financial measure – See reconciliation tables
© 2019 Brooks Automation, Inc. • Proprietary Information 84
• Market leader with broadest end-to-end sample solutions
• Building on strong platform with 80% of revenue growing steadily and high recurring base
• Addressing short-term challenges
• Executing plan to re-accelerate top line growth
I N S U M M A R Y
The Growth Trajectory Remains Strong:Returning to Double-Digit Growth